10 XP 0   0   5  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

EQ (Equillium Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Equillium Inc together

I guess you are interested in Equillium Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Equillium Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Equillium Inc’s Price Targets

I'm going to help you getting a better view of Equillium Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Equillium Inc

I send you an email if I find something interesting about Equillium Inc.

1. Quick Overview

1.1. Quick analysis of Equillium Inc (30 sec.)










1.2. What can you expect buying and holding a share of Equillium Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.14
Expected worth in 1 year
$-0.33
How sure are you?
22.6%

+ What do you gain per year?

Total Gains per Share
$-0.47
Return On Investment
-30.8%

For what price can you sell your share?

Current Price per Share
$1.53
Expected price per share
$1.5 - $2.908
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Equillium Inc (5 min.)




Live pricePrice per Share (EOD)
$1.53
Intrinsic Value Per Share
$8.19 - $10.02
Total Value Per Share
$8.33 - $10.16

2.2. Growth of Equillium Inc (5 min.)




Is Equillium Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$5m$22.5m-$8m-55.9%

How much money is Equillium Inc making?

Current yearPrevious yearGrowGrow %
Making money-$5m-$2m-$2.9m-58.8%
Net Profit Margin-33.0%-22.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Equillium Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#622 / 853

Most Revenue
#355 / 853

Most Profit
#414 / 853

Most Efficient
#377 / 853
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Equillium Inc?

Welcome investor! Equillium Inc's management wants to use your money to grow the business. In return you get a share of Equillium Inc.

First you should know what it really means to hold a share of Equillium Inc. And how you can make/lose money.

Speculation

The Price per Share of Equillium Inc is $1.53. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Equillium Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Equillium Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.14. Based on the TTM, the Book Value Change Per Share is $-0.12 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Equillium Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.16-10.5%-0.14-9.2%-0.06-3.8%-0.11-7.0%-0.21-13.9%-0.19-12.3%
Usd Book Value Change Per Share-0.15-10.1%-0.12-7.7%-0.04-2.3%-0.08-5.4%-0.04-2.4%0.000.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.15-10.1%-0.12-7.7%-0.04-2.3%-0.08-5.4%-0.04-2.4%0.000.3%
Usd Price Per Share0.32-0.57-1.12-0.96-2.57-2.78-
Price to Earnings Ratio-0.50--265.86-0.37--88.66--55.06--37.19-
Price-to-Total Gains Ratio-2.07-3.26--12.77--4.67--7.42--11.67-
Price to Book Ratio2.26-1.57-1.82-1.62-1.96-2.06-
Price-to-Total Gains Ratio-2.07-3.26--12.77--4.67--7.42--11.67-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.53
Number of shares653
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.12-0.04
Usd Total Gains Per Share-0.12-0.04
Gains per Quarter (653 shares)-76.98-23.69
Gains per Year (653 shares)-307.92-94.76
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-308-3180-95-105
20-616-6260-190-200
30-924-9340-284-295
40-1232-12420-379-390
50-1540-15500-474-485
60-1848-18580-569-580
70-2155-21660-663-675
80-2463-24740-758-770
90-2771-27820-853-865
100-3079-30900-948-960

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%2.010.00.016.7%2.018.00.010.0%2.029.00.06.5%2.029.00.06.5%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%5.015.00.025.0%7.024.00.022.6%7.024.00.022.6%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.031.00.0%0.00.031.00.0%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%5.015.00.025.0%7.024.00.022.6%7.024.00.022.6%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Equillium Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.155-0.118-24%-0.036-77%-0.082-47%-0.036-77%0.005-3486%
Book Value Per Share--0.1420.405-65%0.628-77%0.616-77%1.153-88%1.037-86%
Current Ratio--1.6522.832-42%1.923-14%2.419-32%6.191-73%9.098-82%
Debt To Asset Ratio--0.5920.386+54%0.527+12%0.483+23%0.374+58%0.468+26%
Debt To Equity Ratio--1.4520.716+103%1.127+29%1.015+43%0.720+102%0.518+180%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--15582181.44031254625.173-50%52720987.559-70%49215609.911-68%127509758.046-88%152388411.071-90%
Eps---0.161-0.141-12%-0.058-64%-0.108-33%-0.213+33%-0.188+17%
Ev To Ebitda Ratio---0.62998.108-101%0.787-180%32.667-102%16.973-104%10.107-106%
Free Cash Flow Per Share---0.084-0.155+84%-0.111+31%-0.087+4%-0.149+77%-0.135+60%
Free Cash Flow To Equity Per Share---0.085-0.154+82%-0.111+31%-0.115+35%-0.079-6%0.053-260%
Gross Profit Margin--1.0001.0000%0.988+1%0.996+0%0.998+0%0.998+0%
Intrinsic Value_10Y_max--10.022----------
Intrinsic Value_10Y_min--8.190----------
Intrinsic Value_1Y_max---0.154----------
Intrinsic Value_1Y_min---0.152----------
Intrinsic Value_3Y_max--0.420----------
Intrinsic Value_3Y_min--0.383----------
Intrinsic Value_5Y_max--2.058----------
Intrinsic Value_5Y_min--1.834----------
Market Cap54650529.000+79%11430181.44020471625.173-44%40033237.559-71%34336943.244-67%91933608.046-88%99248487.062-88%
Net Profit Margin----0.3300%-0.2240%-0.2320%-0.1390%-0.0900%
Operating Margin----0.3090%-0.2110%-0.2200%-0.1320%-0.0850%
Operating Ratio---0.784-100%1.258-100%0.992-100%0.595-100%0.384-100%
Pb Ratio10.809+79%2.2611.567+44%1.821+24%1.620+40%1.963+15%2.065+9%
Pe Ratio-2.381-378%-0.498-265.857+53294%0.367-236%-88.663+17707%-55.055+10957%-37.188+7369%
Price Per Share1.530+79%0.3200.573-44%1.117-71%0.960-67%2.573-88%2.778-88%
Price To Free Cash Flow Ratio-4.535-378%-0.948-1.093+15%0.647-247%-0.404-57%-2.607+175%-3.780+299%
Price To Total Gains Ratio-9.897-378%-2.0703.261-163%-12.767+517%-4.669+126%-7.420+258%-11.669+464%
Quick Ratio--1.5943.117-49%2.605-39%2.999-47%8.350-81%12.074-87%
Return On Assets---0.463-0.302-35%-0.041-91%-0.143-69%-0.168-64%-0.180-61%
Return On Equity---1.135-0.564-50%-0.092-92%-0.271-76%-0.274-76%-0.219-81%
Total Gains Per Share---0.155-0.118-24%-0.036-77%-0.082-47%-0.036-77%0.005-3486%
Usd Book Value--5056000.00014468000.000-65%22552000.000-78%22036000.000-77%41213450.000-88%37058090.387-86%
Usd Book Value Change Per Share---0.155-0.118-24%-0.036-77%-0.082-47%-0.036-77%0.005-3486%
Usd Book Value Per Share--0.1420.405-65%0.628-77%0.616-77%1.153-88%1.037-86%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--15582181.44031254625.173-50%52720987.559-70%49215609.911-68%127509758.046-88%152388411.071-90%
Usd Eps---0.161-0.141-12%-0.058-64%-0.108-33%-0.213+33%-0.188+17%
Usd Free Cash Flow---3013000.000-5536500.000+84%-3943500.000+31%-3122666.667+4%-5333200.000+77%-4810002.935+60%
Usd Free Cash Flow Per Share---0.084-0.155+84%-0.111+31%-0.087+4%-0.149+77%-0.135+60%
Usd Free Cash Flow To Equity Per Share---0.085-0.154+82%-0.111+31%-0.115+35%-0.079-6%0.053-260%
Usd Market Cap54650529.000+79%11430181.44020471625.173-44%40033237.559-71%34336943.244-67%91933608.046-88%99248487.062-88%
Usd Price Per Share1.530+79%0.3200.573-44%1.117-71%0.960-67%2.573-88%2.778-88%
Usd Profit---5739000.000-5048500.000-12%-2079500.000-64%-3803583.333-34%-8769100.000+53%-7407638.032+29%
Usd Revenue---4138250.000-100%10655750.000-100%7744833.333-100%4646900.000-100%2998000.000-100%
Usd Total Gains Per Share---0.155-0.118-24%-0.036-77%-0.082-47%-0.036-77%0.005-3486%
 EOD+5 -3MRQTTM+7 -27YOY+11 -243Y+10 -255Y+10 -2510Y+10 -25

3.3 Fundamental Score

Let's check the fundamental score of Equillium Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.381
Price to Book Ratio (EOD)Between0-110.809
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.594
Current Ratio (MRQ)Greater than11.652
Debt to Asset Ratio (MRQ)Less than10.592
Debt to Equity Ratio (MRQ)Less than11.452
Return on Equity (MRQ)Greater than0.15-1.135
Return on Assets (MRQ)Greater than0.05-0.463
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Equillium Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.917
Ma 20Greater thanMa 501.773
Ma 50Greater thanMa 1001.061
Ma 100Greater thanMa 2000.715
OpenGreater thanClose1.610
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Equillium Inc

Equillium, Inc., a clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need in the United States. Its lead product candidate is Itolizumab (EQ001), a first-in-class anti-CD6 immune-modifying monoclonal antibody, which is in phase 3 clinical trial to treat acute graft-versus-host disease, as well as completed Phase 1b clinical trial to treat systemic lupus erythematosus and lupus nephritis and in phase 2 clinical trial for the treatment of ulcerative colitis. The company also develops EQ101, first-in-class, selective, tri-specific inhibitor of IL-2, IL-9 and IL-15, which completed Phase 1/2 to treat cutaneous T cell lymphoma. It serves its products to gastroenterology, dermatology, hematology, transplant science, rheumatology, pulmonology, and oncology areas. The company has a collaboration and license agreement with Biocon SA to develop, make, have made, use, sell, have sold, offer for sale, import and otherwise exploit itolizumab (EQ001) and any pharmaceutical composition or preparation containing or comprising itolizumab (EQ001) that uses Biocon technology or Biocon know-how, or collectively, a Biocon Product. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.

Fundamental data was last updated by Penke on 2025-09-03 21:43:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Equillium Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Equillium Inc to theΒ Biotechnology industry mean.
  • A Net Profit Margin of 0.0%Β means thatΒ $0.00 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Equillium Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-33.0%+33.0%
TTM-33.0%YOY-22.4%-10.6%
TTM-33.0%5Y-13.9%-19.1%
5Y-13.9%10Y-9.0%-4.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--85.5%+85.5%
TTM-33.0%-171.0%+138.0%
YOY-22.4%-210.0%+187.6%
3Y-23.2%-289.9%+266.7%
5Y-13.9%-381.1%+367.2%
10Y-9.0%-520.3%+511.3%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Equillium Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Equillium Inc to theΒ Biotechnology industry mean.
  • -46.3% Return on Assets means thatΒ Equillium Inc generatedΒ $-0.46 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Equillium Inc:

  • The MRQ is -46.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -30.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-46.3%TTM-30.2%-16.1%
TTM-30.2%YOY-4.1%-26.0%
TTM-30.2%5Y-16.8%-13.4%
5Y-16.8%10Y-18.0%+1.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-46.3%-11.9%-34.4%
TTM-30.2%-11.9%-18.3%
YOY-4.1%-11.2%+7.1%
3Y-14.3%-12.0%-2.3%
5Y-16.8%-11.7%-5.1%
10Y-18.0%-13.8%-4.2%
4.3.1.3. Return on Equity

Shows how efficient Equillium Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Equillium Inc to theΒ Biotechnology industry mean.
  • -113.5% Return on Equity means Equillium Inc generated $-1.14Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Equillium Inc:

  • The MRQ is -113.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -56.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-113.5%TTM-56.4%-57.1%
TTM-56.4%YOY-9.2%-47.3%
TTM-56.4%5Y-27.4%-29.1%
5Y-27.4%10Y-21.9%-5.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-113.5%-14.2%-99.3%
TTM-56.4%-15.2%-41.2%
YOY-9.2%-15.3%+6.1%
3Y-27.1%-16.9%-10.2%
5Y-27.4%-17.5%-9.9%
10Y-21.9%-19.6%-2.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Equillium Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Equillium Inc is operatingΒ .

  • Measures how much profit Equillium Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Equillium Inc to theΒ Biotechnology industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Equillium Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-30.9%+30.9%
TTM-30.9%YOY-21.1%-9.9%
TTM-30.9%5Y-13.2%-17.8%
5Y-13.2%10Y-8.5%-4.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--154.1%+154.1%
TTM-30.9%-280.2%+249.3%
YOY-21.1%-268.7%+247.6%
3Y-22.0%-281.5%+259.5%
5Y-13.2%-350.8%+337.6%
10Y-8.5%-530.7%+522.2%
4.3.2.2. Operating Ratio

Measures how efficient Equillium Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Equillium Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.784-0.784
TTM0.784YOY1.258-0.473
TTM0.7845Y0.595+0.189
5Y0.59510Y0.384+0.211
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.952-1.952
TTM0.7842.974-2.190
YOY1.2583.047-1.789
3Y0.9923.835-2.843
5Y0.5954.924-4.329
10Y0.3846.864-6.480
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Equillium Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Equillium Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 1.65Β means the company has $1.65 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Equillium Inc:

  • The MRQ is 1.652. The company is able to pay all its short-term debts. +1
  • The TTM is 2.832. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.652TTM2.832-1.179
TTM2.832YOY1.923+0.909
TTM2.8325Y6.191-3.360
5Y6.19110Y9.098-2.907
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6523.480-1.828
TTM2.8323.790-0.958
YOY1.9234.104-2.181
3Y2.4194.609-2.190
5Y6.1915.764+0.427
10Y9.0986.154+2.944
4.4.3.2. Quick Ratio

Measures if Equillium Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Equillium Inc to theΒ Biotechnology industry mean.
  • A Quick Ratio of 1.59Β means the company can pay off $1.59 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Equillium Inc:

  • The MRQ is 1.594. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.117. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.594TTM3.117-1.523
TTM3.117YOY2.605+0.512
TTM3.1175Y8.350-5.234
5Y8.35010Y12.074-3.724
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5942.938-1.344
TTM3.1173.291-0.174
YOY2.6053.928-1.323
3Y2.9994.393-1.394
5Y8.3505.837+2.513
10Y12.0746.549+5.525
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Equillium Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Equillium IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Equillium Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.59Β means that Equillium Inc assets areΒ financed with 59.2% credit (debt) and the remaining percentage (100% - 59.2%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Equillium Inc:

  • The MRQ is 0.592. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.386. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.592TTM0.386+0.207
TTM0.386YOY0.527-0.142
TTM0.3865Y0.374+0.012
5Y0.37410Y0.468-0.095
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5920.339+0.253
TTM0.3860.359+0.027
YOY0.5270.334+0.193
3Y0.4830.341+0.142
5Y0.3740.349+0.025
10Y0.4680.379+0.089
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Equillium Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Equillium Inc to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 145.2% means that company has $1.45 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Equillium Inc:

  • The MRQ is 1.452. The company is able to pay all its debts with equity. +1
  • The TTM is 0.716. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ1.452TTM0.716+0.736
TTM0.716YOY1.127-0.411
TTM0.7165Y0.720-0.004
5Y0.72010Y0.518+0.201
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4520.391+1.061
TTM0.7160.436+0.280
YOY1.1270.436+0.691
3Y1.0150.461+0.554
5Y0.7200.461+0.259
10Y0.5180.514+0.004
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Equillium Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ Equillium Inc to theΒ Biotechnology industry mean.
  • A PE ratio of -0.50 means the investor is paying $-0.50Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Equillium Inc:

  • The EOD is -2.381. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.498. Based on the earnings, the company is expensive. -2
  • The TTM is -265.857. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.381MRQ-0.498-1.883
MRQ-0.498TTM-265.857+265.359
TTM-265.857YOY0.367-266.224
TTM-265.8575Y-55.055-210.802
5Y-55.05510Y-37.188-17.867
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.381-2.539+0.158
MRQ-0.498-2.361+1.863
TTM-265.857-2.657-263.200
YOY0.367-3.749+4.116
3Y-88.663-3.883-84.780
5Y-55.055-6.353-48.702
10Y-37.188-7.102-30.086
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Equillium Inc:

  • The EOD is -4.535. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.948. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.093. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.535MRQ-0.948-3.586
MRQ-0.948TTM-1.093+0.144
TTM-1.093YOY0.647-1.739
TTM-1.0935Y-2.607+1.515
5Y-2.60710Y-3.780+1.172
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.535-3.411-1.124
MRQ-0.948-2.951+2.003
TTM-1.093-3.614+2.521
YOY0.647-4.421+5.068
3Y-0.404-5.258+4.854
5Y-2.607-8.587+5.980
10Y-3.780-9.639+5.859
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Equillium Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 2.26 means the investor is paying $2.26Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Equillium Inc:

  • The EOD is 10.809. Based on the equity, the company is expensive. -2
  • The MRQ is 2.261. Based on the equity, the company is underpriced. +1
  • The TTM is 1.567. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD10.809MRQ2.261+8.548
MRQ2.261TTM1.567+0.693
TTM1.567YOY1.821-0.253
TTM1.5675Y1.963-0.395
5Y1.96310Y2.065-0.102
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD10.8092.206+8.603
MRQ2.2612.027+0.234
TTM1.5672.194-0.627
YOY1.8212.425-0.604
3Y1.6202.571-0.951
5Y1.9633.805-1.842
10Y2.0654.462-2.397
4.6.2. Total Gains per Share

2.4. Latest News of Equillium Inc

Does Equillium Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Equillium Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-09-11
10:00
Press Releases and AI Search: What PR Pros Need to Know NowRead
2025-08-22
18:30
Friday's session: top gainers and losersRead
2025-08-21
21:00
Top stock movements in today's session.Read

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Equillium Inc.

4.8.1. Institutions holding Equillium Inc

Institutions are holding 11.737% of the shares of Equillium Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-06-30Decheng Capital LLC12.45070.354444730800
2025-06-30Takeda Pharmaceutical Co Ltd5.10922.9418182497700
2025-06-30Vanguard Group Inc2.30710824091-17857-2.1209
2025-06-30Cota Capital Management, LLC1.574210056227800
2025-03-31Renaissance Technologies Corp0.75450.000226950081003.0987
2025-03-31Geode Capital Management, LLC0.574902053679820.4805
2025-03-31Acadian Asset Management LLC0.30430.00011086911086910
2025-03-31Callan Capital, LLC0.27910.00299968800
2025-03-31State Street Corp0.167205972000
2025-03-31Citadel Advisors Llc0.1558055649556490
2025-03-31BlackRock Inc0.1035036967-702-1.8636
2025-03-31Northern Trust Corp0.09803501900
2025-03-31Commonwealth Equity Services Inc0.0702500000
2025-03-31Virtu Financial LLC0.03910.000313954-1735-11.0587
2025-06-30Apollon Wealth Management, LLC0.03880.000113875138750
2025-06-30TRITONPOINT WEALTH LLC0.03780.00041350000
2025-03-31Morgan Stanley - Brokerage Accounts0.0287010238335348.7001
2025-06-30Tower Research Capital LLC0.01820.00016514-305-4.4728
2025-03-31UBS Group AG0.004801722-15587-90.0514
2025-03-31Wells Fargo & Co0.00280100000
Total 24.1187103.29998615058+154464+1.8%

4.9.2. Funds holding Equillium Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-07-31Vanguard Total Stock Mkt Idx Inv1.56390558626-12209-2.1388
2025-07-31Vanguard Institutional Extnd Mkt Idx Tr0.47590.0001169977-77453-31.303
2025-06-30Fidelity Extended Market Index0.27950.00019983900
2025-06-30PGIM Quantitative Solutions US Micro Cap0.10970.14739200392000
2025-06-30Fidelity Total Market Index0.098703524000
2025-06-30Fidelity Series Total Market Index0.068702455400
2025-06-30Spartan Extended Market Index Pool F0.05010.00011789700
2024-12-31Vanguard Instl Ttl Stck Mkt Idx Tr0.050.00011785700
2025-06-30NT Ext Equity Mkt Idx Fd - NL0.04730.00011689600
2025-06-30NT Ext Equity Mkt Idx Fd - L0.04590.00011638000
2025-06-30Northern Trust Extended Eq Market Idx0.04590.00011638000
2025-06-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.03670.000113120-33-0.2509
2025-06-30Fidelity Nasdaq Composite Index0.02640942500
2025-06-30Spartan Total Market Index Pool G0.02530903300
2025-07-31Vanguard U.S. Eq Idx Β£ Acc0.01630582600
2025-06-30NT Ext Eq Mkt Indx Fd DC Lending Tier 50.01290.0001462268817.4886
2025-07-31State St US Extended Mkt Indx NL Cl C0.01150.0001410000
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T30.01090.0002390339030
2025-07-31State St US Ttl Mkt Indx NL Cl A0.00590210000
2025-06-30Northern Trust Wilshire 50000.00490174300
Total 2.98640.14821066718-45904-4.3%

5.3. Insider Transactions

Insiders are holding 21.549% of the shares of Equillium Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-01-23Jason A KeyesSELL100000.65
2024-11-14Jason A KeyesSELL100000.7
2024-10-28Christine ZedelmayerSELL150001.25
2024-10-28Penny TomSELL28351.25
2024-10-25Penny TomSELL6831.25
2024-09-26Jason A KeyesSELL100000.81
2024-09-16Penny TomSELL388060.85
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets12,399
Total Liabilities7,343
Total Stockholder Equity5,056
 As reported
Total Liabilities 7,343
Total Stockholder Equity+ 5,056
Total Assets = 12,399

Assets

Total Assets12,399
Total Current Assets11,952
Long-term Assets447
Total Current Assets
Cash And Cash Equivalents 11,495
Net Receivables 35
Other Current Assets 422
Total Current Assets  (as reported)11,952
Total Current Assets  (calculated)11,952
+/-0
Long-term Assets
Property Plant Equipment 447
Long-term Assets  (as reported)447
Long-term Assets  (calculated)447
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities7,234
Long-term Liabilities109
Total Stockholder Equity5,056
Total Current Liabilities
Short-term Debt 150
Accounts payable 4,812
Other Current Liabilities 2,255
Total Current Liabilities  (as reported)7,234
Total Current Liabilities  (calculated)7,217
+/- 17
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt109
Long-term Liabilities  (as reported)109
Long-term Liabilities  (calculated)109
+/-0
Total Stockholder Equity
Common Stock3
Retained Earnings -208,200
Accumulated Other Comprehensive Income 385
Other Stockholders Equity 212,868
Total Stockholder Equity (as reported)5,056
Total Stockholder Equity (calculated)5,056
+/-0
Other
Capital Stock3
Cash and Short Term Investments 11,495
Common Stock Shares Outstanding 35,719
Liabilities and Stockholders Equity 12,399
Net Debt -11,236
Net Invested Capital 5,056
Net Working Capital 4,718
Property Plant and Equipment Gross 447
Short Long Term Debt Total 259



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
> Total Assets 
0
0
7,151
6,728
6,728
6,422
67,163
62,727
57,888
62,995
55,539
49,911
44,259
92,385
85,428
106,838
99,837
92,470
85,405
74,235
62,472
48,631
78,421
71,790
58,764
55,225
50,530
43,597
42,861
34,457
25,604
16,729
12,399
12,39916,72925,60434,45742,86143,59750,53055,22558,76471,79078,42148,63162,47274,23585,40592,47099,837106,83885,42892,38544,25949,91155,53962,99557,88862,72767,1636,4226,7286,7287,15100
   > Total Current Assets 
0
0
7,149
6,706
6,706
5,060
67,163
62,629
57,796
62,909
55,539
49,822
44,178
92,160
85,428
106,615
99,566
92,170
83,760
72,085
60,482
46,776
77,230
70,220
57,356
53,911
49,349
42,480
41,887
33,646
24,978
16,216
11,952
11,95216,21624,97833,64641,88742,48049,34953,91157,35670,22077,23046,77660,48272,08583,76092,17099,566106,61585,42892,16044,17849,82255,53962,90957,79662,62967,1635,0606,7066,7067,14900
       Cash And Cash Equivalents 
0
0
7,103
6,626
6,626
4,983
28,509
21,394
22,661
27,657
13,219
20,614
24,083
49,249
23,982
50,861
73,525
77,155
50,366
26,244
23,808
25,729
59,107
24,503
25,624
34,382
23,216
11,568
11,057
15,448
18,085
14,502
11,495
11,49514,50218,08515,44811,05711,56823,21634,38225,62424,50359,10725,72923,80826,24450,36677,15573,52550,86123,98249,24924,08320,61413,21927,65722,66121,39428,5094,9836,6266,6267,10300
       Short-term Investments 
0
0
0
0
0
0
37,405
40,213
34,283
34,581
39,924
27,061
18,523
41,288
58,181
53,218
24,118
13,539
30,345
42,579
33,754
18,793
11,916
37,489
22,754
11,924
17,650
20,717
22,242
10,429
4,490
0
0
004,49010,42922,24220,71717,65011,92422,75437,48911,91618,79333,75442,57930,34513,53924,11853,21858,18141,28818,52327,06139,92434,58134,28340,21337,405000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,838
3,424
3,743
3,769
6,286
8,490
6,992
6,196
1,144
1,045
35
351,0451,1446,1966,9928,4906,2863,7693,7433,4242,8380000000000000000000000
       Other Current Assets 
0
0
46
0
80
156
1,186
2,044
1,704
1,342
2,288
4,294
3,144
3,246
3,265
5,072
3,846
2,952
3,049
6,524
5,840
4,508
4,465
4,804
5,235
3,836
2,197
1,705
1,596
1,573
1,259
669
422
4226691,2591,5731,5961,7052,1973,8365,2354,8044,4654,5085,8406,5243,0492,9523,8465,0723,2653,2463,1444,2942,2881,3421,7042,0441,1861568004600
   > Long-term Assets 
0
0
0
0
22
1,361
64
98
92
86
108
89
81
225
254
223
271
300
1,645
2,150
1,990
1,855
1,191
1,570
1,408
1,314
1,181
1,117
974
811
626
513
447
4475136268119741,1171,1811,3141,4081,5701,1911,8551,9902,1501,6453002712232542258189108869298641,361220000
       Property Plant Equipment 
0
0
2
22
22
32
64
83
77
71
93
89
81
225
239
223
254
243
1,645
2,005
1,869
1,742
1,191
1,474
1,321
1,235
1,111
1,055
921
766
626
513
447
4475136267669211,0551,1111,2351,3211,4741,1911,7421,8692,0051,64524325422323922581899371778364322222200
       Intangible Assets 
0
0
0
0
0
0
23
0
0
0
38
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000003800023000000
       Other Assets 
0
0
0
0
0
1,329
-64
15
15
15
-108
0
0
0
-254
0
17
57
153
145
121
113
3,369
0
87
79
0
0
0
0
0
0
0
0000000798703,36911312114515357170-254000-108151515-641,32900000
> Total Liabilities 
0
0
9,403
12,322
589
16,800
2,228
3,233
3,825
14,036
13,691
13,565
13,287
14,259
15,574
14,958
15,064
16,668
18,900
21,605
22,205
20,471
46,479
42,521
31,783
31,117
27,957
22,503
20,428
11,280
6,543
6,151
7,343
7,3436,1516,54311,28020,42822,50327,95731,11731,78342,52146,47920,47122,20521,60518,90016,66815,06414,95815,57414,25913,28713,56513,69114,0363,8253,2332,22816,80058912,3229,40300
   > Total Current Liabilities 
0
0
569
917
581
2,680
2,028
3,052
3,662
4,274
3,883
3,711
3,387
5,145
7,245
7,417
4,980
7,778
8,915
13,113
15,188
14,930
32,038
32,020
25,218
28,199
27,573
22,208
20,169
11,057
6,356
6,002
7,234
7,2346,0026,35611,05720,16922,20827,57328,19925,21832,02032,03814,93015,18813,1138,9157,7784,9807,4177,2455,1453,3873,7113,8834,2743,6623,0522,0282,68058191756900
       Short-term Debt 
0
0
8,059
10,518
10,518
0
0
0
0
0
0
0
0
833
1,666
2,500
10,067
1,250
1,804
3,697
5,154
6,556
6,122
6,522
832
856
880
848
700
548
197
146
150
1501461975487008488808568326,5226,1226,5565,1543,6971,8041,25010,0672,5001,6668330000000010,51810,5188,05900
       Short Long Term Debt 
0
0
8,059
10,518
10,518
0
0
0
0
0
0
0
0
833
1,666
2,500
0
1,250
1,428
2,857
4,286
5,714
5,714
5,714
0
0
0
0
0
0
0
0
0
0000000005,7145,7145,7144,2862,8571,4281,25002,5001,6668330000000010,51810,5188,05900
       Accounts payable 
0
0
244
347
347
1,230
1,119
1,588
1,974
2,675
1,873
1,801
1,761
1,681
2,766
2,324
1,816
2,669
1,225
4,210
5,091
2,469
3,977
5,692
3,026
3,635
4,707
2,778
4,486
3,666
2,676
3,058
4,812
4,8123,0582,6763,6664,4862,7784,7073,6353,0265,6923,9772,4695,0914,2101,2252,6691,8162,3242,7661,6811,7611,8011,8732,6751,9741,5881,1191,23034734724400
       Other Current Liabilities 
0
0
141
0
234
1,449
909
1,464
1,688
1,599
2,010
1,910
1,626
2,631
2,813
2,593
3,164
3,859
5,886
5,206
4,943
5,905
7,239
9,102
12,401
12,265
9,460
5,646
6,553
4,775
3,118
2,433
2,255
2,2552,4333,1184,7756,5535,6469,46012,26512,4019,1027,2395,9054,9435,2065,8863,8593,1642,5932,8132,6311,6261,9102,0101,5991,6881,4649091,449234014100
   > Long-term Liabilities 
0
0
0
0
8
14,121
200
181
163
9,762
9,808
9,854
9,900
9,114
8,329
7,541
10,084
8,890
9,985
8,492
7,017
5,541
14,441
10,501
6,565
2,918
384
295
259
223
187
149
109
1091491872232592953842,9186,56510,50114,4415,5417,0178,4929,9858,89010,0847,5418,3299,1149,9009,8549,8089,76216318120014,12180000
       Long term Debt Total 
0
0
0
0
0
10,322
0
0
0
9,616
9,681
9,746
9,810
9,043
8,275
0
0
8,873
8,750
7,370
5,992
0
0
0
0
0
0
0
0
0
0
0
0
0000000000005,9927,3708,7508,873008,2759,0439,8109,7469,6819,61600010,32200000
       Other Liabilities 
0
0
776
887
887
2,524
200
181
163
146
127
108
90
71
54
35
17
17
0
0
0
0
10,378
0
5,956
2,420
0
0
0
0
0
0
0
00000002,4205,956010,37800001717355471901081271461631812002,52488788777600
       Deferred Long Term Liability 
0
0
0
0
0
1,329
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000001,32900000
> Total Stockholder Equity
0
0
-2,252
-2,252
6,139
-10,379
64,935
59,494
54,063
48,959
41,848
36,346
30,972
78,126
69,854
91,880
84,773
75,802
66,505
52,630
40,267
28,160
31,942
29,269
26,981
24,108
22,573
21,094
22,433
23,177
19,061
10,578
5,056
5,05610,57819,06123,17722,43321,09422,57324,10826,98129,26931,94228,16040,26752,63066,50575,80284,77391,88069,85478,12630,97236,34641,84848,95954,06359,49464,935-10,3796,139-2,252-2,25200
   Common Stock
0
0
0
0
0
0
1
1
1
1
1
1
1
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
3
3
3
3
333333333333332222221111111000000
   Retained Earnings Total Equity000000000000-161,523-147,394-109,977-99,356-89,074-79,916-70,925-62,007-55,410-48,949-41,112-33,545-27,531-21,462-15,512-10,52000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
5
49
87
80
21
474
97
-30
-297
-255
-209
-66
-138
-454
-149
193
76
305
340
458
140
423
251
-3
781
731
385
385731781-325142314045834030576193-149-454-138-66-209-255-297-3097474218087495000000
   Capital Surplus 
0
0
0
0
0
142
80,441
80,906
81,506
82,423
82,938
84,820
86,284
140,161
141,074
172,049
174,054
175,222
176,618
200,475
201,936
0
0
0
0
0
0
0
0
0
0
0
0
000000000000201,936200,475176,618175,222174,054172,049141,074140,16186,28484,82082,93882,42381,50680,90680,44114200000
   Treasury Stock000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
11,743
142
80,447
80,906
81,506
82,423
82,938
84,820
86,284
140,161
141,074
172,049
174,054
175,222
176,618
200,475
201,936
203,142
204,268
205,306
206,326
207,045
208,170
209,142
210,185
211,190
212,084
212,305
212,868
212,868212,305212,084211,190210,185209,142208,170207,045206,326205,306204,268203,142201,936200,475176,618175,222174,054172,049141,074140,16186,28484,82082,93882,42381,50680,90680,44714211,7430000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue41,095
Cost of Revenue-137
Gross Profit40,95840,958
 
Operating Income (+$)
Gross Profit40,958
Operating Expense-49,364
Operating Income-8,269-8,406
 
Operating Expense (+$)
Research Development37,428
Selling General Administrative11,936
Selling And Marketing Expenses0
Operating Expense49,36449,364
 
Net Interest Income (+$)
Interest Income1,381
Interest Expense-0
Other Finance Cost-0
Net Interest Income1,381
 
Pretax Income (+$)
Operating Income-8,269
Net Interest Income1,381
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-7,706-8,832
EBIT - interestExpense = -7,706
-7,706
-8,067
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-7,706-7,706
Earnings Before Interest and Taxes (EBITDA)-7,569
 
After tax Income (+$)
Income Before Tax-7,706
Tax Provision-361
Net Income From Continuing Ops-8,067-8,067
Net Income-8,067
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses49,364
Total Other Income/Expenses Net563-1,381
 

Technical Analysis of Equillium Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Equillium Inc. The general trend of Equillium Inc is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Equillium Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Equillium Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Equillium Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 2.26 < 2.35 < 2.908.

The bearish price targets are: 1.53 > 1.5 > 1.5.

Know someone who trades $EQ? Share this with them.πŸ‘‡

Equillium Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Equillium Inc. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Equillium Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Equillium Inc. The current macd is 0.17893986.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Equillium Inc price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Equillium Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Equillium Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Equillium Inc Daily Moving Average Convergence/Divergence (MACD) ChartEquillium Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Equillium Inc. The current adx is 63.55.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Equillium Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Equillium Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Equillium Inc. The current sar is 2.3348.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Equillium Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Equillium Inc. The current rsi is 49.92. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Equillium Inc Daily Relative Strength Index (RSI) ChartEquillium Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Equillium Inc. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Equillium Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Equillium Inc Daily Stochastic Oscillator ChartEquillium Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Equillium Inc. The current cci is -87.95278671.

Equillium Inc Daily Commodity Channel Index (CCI) ChartEquillium Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Equillium Inc. The current cmo is -18.13838077.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Equillium Inc Daily Chande Momentum Oscillator (CMO) ChartEquillium Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Equillium Inc. The current willr is -96.47058824.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Equillium Inc Daily Williams %R ChartEquillium Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Equillium Inc.

Equillium Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Equillium Inc. The current atr is 0.25917996.

Equillium Inc Daily Average True Range (ATR) ChartEquillium Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Equillium Inc. The current obv is 499,497,542.

Equillium Inc Daily On-Balance Volume (OBV) ChartEquillium Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Equillium Inc. The current mfi is 54.57.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Equillium Inc Daily Money Flow Index (MFI) ChartEquillium Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Equillium Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-04-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-05-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-05-30STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-03WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-06-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-06-17STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-23STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-07-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-02STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-07-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-23STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-07-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-07-29STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-31CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-08-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-08-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-08-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-29MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-09-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-09-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-05MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-09-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-09-10MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-09-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-09-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Equillium Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Equillium Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.917
Ma 20Greater thanMa 501.773
Ma 50Greater thanMa 1001.061
Ma 100Greater thanMa 2000.715
OpenGreater thanClose1.610
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Equillium Inc with someone you think should read this too:
  • Are you bullish or bearish on Equillium Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Equillium Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Equillium Inc

I send you an email if I find something interesting about Equillium Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Equillium Inc.

Receive notifications about Equillium Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.